Celyad announces management change

MONT-SAINT-GUIBERT, Belgium, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD), a cutting-edge biotechnology company dedicated ...

Related Keywords

Belgium ,Mont Saint Guibert ,Waals Gewest ,New York ,United States ,Hilde Windels ,Michel Lussier ,Georges Rawadi ,David Georges ,Exchange Commission ,Friday December ,Celyad Oncology ,Private Securities Litigation Reform Act ,Annual Report ,Oncology Investor ,Media Contact ,